AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Hemostats and Tissue Sealants Market 2020-2024| Evolving Opportunities with Advanced Medical Solutions Group Plc and CryoLife Inc. | Technavio

January 21, 2020 GMT
Global Hemostats and Tissue Sealants Market 2020-2024| Evolving Opportunities with Advanced Medical Solutions Group Plc and CryoLife Inc. | Technavio
Global Hemostats and Tissue Sealants Market 2020-2024| Evolving Opportunities with Advanced Medical Solutions Group Plc and CryoLife Inc. | Technavio

LONDON--(BUSINESS WIRE)--Jan 21, 2020--

Technavio has been monitoring the global hemostats and tissue sealants market since 2016 and the market is poised to grow by USD 921.95 million during 2020-2024, progressing at a CAGR of over 5% during the forecast period. Request Free Sample Pages

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200121005425/en/

Technavio has announced its latest market research report titled global hemostats and tissue sealants market 2020-2024. (Graphic: Business Wire)

Read the 157-page research report with TOC on “Hemostats and Tissue Sealants Market Analysis Report by Geography (Asia, Europe, North America, and ROW), by Product (Hemostats, Tissue sealants and adhesives, and Fibrin sealants), and Segment Forecasts, 2020-2024”.

https://www.technavio.com/report/hemostats-and-tissue-sealants-market-industry-analysis

The use of hemostats and tissue sealants in surgeries and increasing R&D on novel hemostats and tissue sealants are factors anticipated to boost the growth of the market.

Surgical procedures involve clinical consequences such as bleeding and leakage of body fluids. Such adverse events can lead to reduced oxygen supply to vital tissues, hemodynamic instability, increased risk of organ failure, anemia, and hypovolemia. This is driving the demand for hemostats to minimize blood loss and surgical sealants to seal suture lines and prevent leaks. Hemostats are gaining traction in the market as they do not require removal, inflicts lesser pain, and achieve hemostasis in a shorter time. Hemostats and tissue sealants are extensively used in minimally invasive surgeries such as laparoscopic surgeries and percutaneous interventional procedures. Thus, the growing use of hemostats and tissue sealants in surgeries is expected to drive market growth during the forecast period.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Hemostats and Tissue Sealants Market Companies:

Advanced Medical Solutions Group Plc

Advanced Medical Solutions Group Plc is headquartered in the UK and operates the business under various segments such as Surgical and Woundcare. The company offers a range of tissue sealants such as LiquiBand Topical Skin Adhesives, LiquiBand Fix8, Seal-G, and Seal-G MIST.

B. Braun Melsungen AG

B. Braun Melsungen AG is headquartered in Germany and offers products through the following business units: Hospital Care, Aesculapm, OPM, B. Braun Avitum, and Others. The company provides a range of hemostats and tissue sealants such as Histoacryl, Histoacryl Flexible, Sangustop, Lyostypt, Cellistypt, Gelita, and Bone Wax.

Baxter International Inc.

Baxter International Inc. is headquartered in the US and operates under various business segments, namely Rental Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies, and Other. The company offers a range of hemostats and tissue sealants such as FLOSEAL Hemostatic Matrix, TISSEEL, COSEAL, and more.

Becton, Dickinson and Co.

Becton, Dickinson and Co. is headquartered in the US and offers products through the following business segments: BD Medical, BD Life Sciences, and BD Interventional. The company provides a range of hemostats and tissue sealants such as Arista Absorbable Hemostat, Avitene Microfibrillar Collagen Hemostat, and more.

CryoLife Inc.

CryoLife Inc. is headquartered in the US and offers products through the following business segments: Medical devices and Preservation services. The company provides BioGlue surgical glue and PerClot polysacchride hemostatic system.

Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform

Hemostats and Tissue Sealants Product Outlook (Revenue, USD Million, 2020-2024)

Hemostats and Tissue Sealants Regional Outlook (Revenue, USD Million, 2020-2024)

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.Request a free sample report

Related Reports on Health Careinclude:

Surgical Sealing Devices Market – Global Surgical Sealing Devices Market by product (surgical suturing and stapling devices, surgical adhesives and sealants, and electrosurgical sealing devices).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200121005425/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email:media@technavio.com

Website:https://www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: SURGERY HEALTH

SOURCE: Technavio Research

Copyright Business Wire 2020.

PUB: 01/21/2020 05:00 AM/DISC: 01/21/2020 05:01 AM

http://www.businesswire.com/news/home/20200121005425/en